Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Baquacil
2. Cosmocil
3. Lavasept
4. Phmb Polymer
5. Polihexanide Hydrochloride
6. Poly(hexamethylene Biguanide)
7. Poly(hexamethylenebiguanide) Hydrochloride
8. Poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl) Hydrochloride
9. Polyhexamethylen-biguanide
10. Polyhexamethylenbiguanid
11. Polyhexamethylenbiguanide
12. Polyhexamethylene Biguanide
13. Polyhexamethylene Biguanide Hydrochloride
14. Polyhexanide
15. Vantocil
16. Vantocil Ib Of Vantocil
1. Polyhexamethylene Biguanide
2. 28757-47-3
3. Polyhexanide
4. 1-(diaminomethylidene)-2-hexylguanidine
5. Lavasept
6. Vantocil
7. Polihexanide Hydrochloride
8. Purista
9. Microcare Mbg
10. Cosmocil Cq
11. N-hexylbiguanide
12. 1-hexylbiguanide
13. Schembl45011
14. Chembl2106939
15. Schembl20753163
16. Dtxsid40873856
17. N-hexylimidodicarbonimidic Diamide
18. Zinc4217340
19. Akos017531707
20. Ft-0700841
21. Q408205
22. 24717-31-5
Molecular Weight | 185.27 g/mol |
---|---|
Molecular Formula | C8H19N5 |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 6 |
Exact Mass | 185.16404563 g/mol |
Monoisotopic Mass | 185.16404563 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 181 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of Acanthamoeba keratitis
Disinfectants
Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley's Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)
D - Dermatologicals
D08 - Antiseptics and disinfectants
D08A - Antiseptics and disinfectants
D08AC - Biguanides and amidines
D08AC05 - Polihexanide
Market Place
ABOUT THIS PAGE
A Polyhexanide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Polyhexanide, including repackagers and relabelers. The FDA regulates Polyhexanide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Polyhexanide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Polyhexanide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Polyhexanide supplier is an individual or a company that provides Polyhexanide active pharmaceutical ingredient (API) or Polyhexanide finished formulations upon request. The Polyhexanide suppliers may include Polyhexanide API manufacturers, exporters, distributors and traders.
click here to find a list of Polyhexanide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Polyhexanide DMF (Drug Master File) is a document detailing the whole manufacturing process of Polyhexanide active pharmaceutical ingredient (API) in detail. Different forms of Polyhexanide DMFs exist exist since differing nations have different regulations, such as Polyhexanide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Polyhexanide DMF submitted to regulatory agencies in the US is known as a USDMF. Polyhexanide USDMF includes data on Polyhexanide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Polyhexanide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Polyhexanide suppliers with USDMF on PharmaCompass.
Polyhexanide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Polyhexanide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Polyhexanide GMP manufacturer or Polyhexanide GMP API supplier for your needs.
A Polyhexanide CoA (Certificate of Analysis) is a formal document that attests to Polyhexanide's compliance with Polyhexanide specifications and serves as a tool for batch-level quality control.
Polyhexanide CoA mostly includes findings from lab analyses of a specific batch. For each Polyhexanide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Polyhexanide may be tested according to a variety of international standards, such as European Pharmacopoeia (Polyhexanide EP), Polyhexanide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Polyhexanide USP).
LOOKING FOR A SUPPLIER?